BOBCARE Launches Internet-Plus Cross-Border Fertility Services, Files IPO Prospectus
Recently, Shi Lei, CEO of Beijing Aibeike Technology Co., Ltd. (hereinafter referred to as “Beibeike”), announced that the company’s international assisted reproductive technology services have been fully launched, aiming to benefit over 40 million patients suffering from infertility.
According to the latest data, China's infertility rate has risen from 3% two decades ago to 12.5–15%, with the number of affected individuals exceeding 40 million. Among every eight couples of childbearing age, one is affected by infertility, making it an increasingly serious social issue. This has led to surging demand in the domestic assisted reproductive technology (ART) market, which is struggling to meet patient needs. Furthermore, there are approximately 90 million couples in China eligible for the two-child policy, including 60 million women aged 35 and older, many of whom require ART services. As a new model of medical consultation and treatment, cross-border reproductive healthcare is gaining recognition and being chosen by a growing number of people.
According to survey data, the cross-border reproductive healthcare market is plagued by chaos due to a lack of regulatory oversight from laws and regulations, making it difficult to standardize pricing. Many intermediary agencies have taken advantage of this situation to charge exorbitant service fees: the total cost for IVF services in Thailand, including medical expenses, ranges from RMB 100,000 to RMB 200,000, while the cost for IVF in the United States is approximately RMB 200,000 to RMB 300,000.
Bei Beike, an internet healthcare platform product, offers international assisted reproductive services designed to help infertility patients understand the most advanced global assisted reproductive technologies and share high-quality medical resources worldwide. Through its online consultation and offline referral services, patients can save time waiting at medical institutions, making treatment more convenient.
Beibeike App Interface
International assisted reproductive services offer multiple packages, including remote initial consultations for Macau, Thailand, and the United States, as well as on-site reproductive services in these destinations for patients to choose from.
The distinctive features of Beibeike International’s assisted reproductive technology services include:
1. Patients can choose their own personalized plans and select medical institutions of different tiers on the Beibeike App for adjunctive therapy, according to their financial capacity;
2. Support phased services, allowing patients to discontinue treatment at any time based on their condition;
3. Joint consultation and assessment by domestic and international experts;
4. Collaborate with industry-leading institutions such as Ivy Medical Center, American Dream Fertility, and Global Reproductive Center;
5. Patients need not worry about language barriers, as professional interpreters will accompany them during consultations;
6. Full-process medical accompaniment.
Bei Bei Ke is an expert-driven fertility assistance app that integrates online consultations with offline referrals. The product team brings together Tsinghua University MBA graduates, specialists in reproductive health, and elites from Fortune 500 companies.
Bei Beike provides users with comprehensive reproductive health services, including online consultations, specialist diagnosis and treatment, and scientifically guided preconception care.
Regarding the product, please refer to the VCBeat article “VCBeat: Profitability Starts with Retaining Doctors》。
Since its establishment last August, Beibeike has successfully established preconception care centers in Beijing, Zhengzhou, Jinan, Guangzhou, and other cities. It has forged strong partnerships with numerous prestigious medical institutions and research institutes, including Peking University Third Hospital, Tsinghua University, and the Chinese Center for Disease Control and Prevention, certifying thousands of reproductive and obstetric-gynecologic physicians. The company has secured exclusive collaborations with more than 20 hotels located near partner hospitals, providing over 2,000 beds dedicated to preconception care. Currently, Beibeike employs more than 60 full-time staff and maintains four offices in Beijing, Shanghai, Shenzhen, and Macau.